Clinical Trials Sponsored by LanthioPep BV

Total 289 results

Centocor, Inc.
Centocor BV

Completed

A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

Crohn Disease
CoreAalst BV
HeartFlow, Inc.

Recruiting

The COMPLETE Study (COMPLETE)

Coronary Artery Disease

Belgium
Acerta Pharma BV
AstraZeneca

Active, not recruiting

Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies

Multiple Myeloma | Non-Hodgkins Lymphoma | B-All

United States
Acerta Pharma BV
AstraZeneca

Active, not recruiting

Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma

Non Hodgkin Lymphoma

United States, Canada, Italy
Acerta Pharma BV
AstraZeneca

Active, not recruiting

A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312) (ESCALADE)

Diffuse Large B-Cell Lymphoma

United States, France, Italy, Spain, Canada, Taiwan, Germany, Korea, Republic of, Brazil, Japan, Russian Federation, Poland, China, Israel, Belgium, Australia, Austria, Czechia, Portugal, Mexico, Turkey, India, Ukraine
Acerta Pharma BV
AstraZeneca

Active, not recruiting

A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCL

Mantle Cell Lymphoma (MCL)

United States, Poland, Italy
Amphera BV
TMC Pharma

Completed

DENdritic Cell Immunotherapy for Mesothelioma (DENIM)

Mesothelioma

Netherlands, France, United Kingdom, Belgium, Italy
AtriCure, Inc.
Cardialysis BV

Active, not recruiting

Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation (CEASE-AF)

Atrial Fibrillation | Persistent and Longstanding Persistent Atrial Fibrillation

Germany, United Kingdom, Netherlands, Czechia, Poland
GATT Technologies BV
Avania

Completed

Clinical Safety and Performance of GATT-Patch in Open Liver Surgery

Hemorrhage, Surgical

Netherlands
Acerta Pharma BV
AstraZeneca

Completed

Investigate the Influence of Severe Hepatic Impairment on the Pharmacokinetics of Acalabrutinib and Its Metabolite

Hepatic Insufficiency | Healthy Subjects | Hepatic Impairment

United States
Philips Electronics Nederland BV

Completed

Blue Light for Treating Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Univar BV
Aptiv Solutions

Completed

A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Wilson's Disease

Germany
Newtricious R&D BV

Completed

Effect of NWT-03 on Blood Pressure

Blood Pressure | Albuminuria

Ireland
Centocor, Inc.
Centocor BV

Completed

A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

Ankylosing Spondylitis
Maastricht University Medical Center
SenterNovem; Newtricious BV; Globus Ei BV

Completed

The Effect of Eggs and Egg Products on Macular Pigment

Age-related Macular Degeneration

Netherlands
Cryotherapeutics SA
CoreAalst BV

Recruiting

Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With NSTEMI or Unstable Angina (POLARSTAR)

Myocardial Infarction | Coronary Artery Disease | Cryotherapy Effect | Coronary Syndrome | Atherosclerosis, Coronary | Myocardial Disease

Lithuania, Georgia
Wageningen University
WholeFiber BV

Not yet recruiting

Impact of a Dried Vegetable on Bowel Function and Gut Microbiota

Bowel Function Dissatisfaction

Netherlands
Aesculape CRO Belgium BV

Recruiting

Study Evaluating the Efficacy and Safety of Miconazole Nitrate + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis

Acute Vulvovaginal Candidiasis

Belgium
Acerta Pharma BV
AstraZeneca

Active, not recruiting

Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL (AMPLIFY)

Chronic Lymphocytic Leukemia

United States, Spain, Canada, Italy, Taiwan, Russian Federation, Turkey, Germany, Korea, Republic of, Brazil, Hungary, Poland, China, Sweden, Bulgaria, Israel, United Kingdom, Australia, Saudi Arabia, Austria, France, Czechia, South... and more
Acerta Pharma BV
AstraZeneca

Active, not recruiting

A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

Lymphoma, Mantle Cell

United States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
Acerta Pharma BV
AstraZeneca

Terminated

Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19

COVID-19

Brazil
AstraZeneca
Acerta Pharma BV

Completed

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. (CALAVI)

COVID-19

Italy, Turkey, Brazil, Japan, South Africa, Germany, Poland, Russian Federation, India, Peru, France, Argentina, Chile, Mexico
AstraZeneca
Acerta Pharma BV

Completed

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. (CALAVI US)

COVID-19

United States
Aeras
Crucell Holland BV

Completed

Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults

HIV Infections | Tuberculosis

South Africa
Qvanteq AG
Cardialysis BV

Completed

Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation

Coronary Artery Disease

Netherlands, Switzerland
Aeras
Crucell Holland BV

Completed

A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB (C-010-402)

Tuberculosis

South Africa
Philips Electronics Nederland BV

Completed

Blue Light for Treating Eczema

Eczema

Germany
Synapse bv
Maastricht University

Completed

The Effect of Strenuous Exercise on Coagulation.

The Effect of Strenuous Exercise on Haemostasis.

Netherlands
Newtricious R&D BV

Completed

Effect of NWT-03 on Blood Pressure - Part 1

Blood Pressure
Centocor, Inc.
Centocor BV

Completed

A Long-term Safety Study of Infliximab (Remicade)

Arthritis, Rheumatoid | Psoriasis | Crohn Disease

United States, Canada, France, Germany, Poland, United Kingdom, Belgium, Spain, Argentina, Israel, Switzerland, Finland, Sweden, Netherlands, Austria, Hungary, Ireland, Norway, Denmark
Centocor, Inc.
Centocor BV

Completed

An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis
Centocor, Inc.
Centocor BV

Completed

A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma

Asthma

United Kingdom, United States, Germany, France, Poland, Bulgaria, Belgium, Czech Republic, Hungary, Netherlands, Sweden
Centocor, Inc.
Centocor BV

Completed

A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis

Multiple Sclerosis
GATT Technologies BV
Syneos Health

Active, not recruiting

GATT-Patch Versus TachoSil in Liver Surgery

Liver Diseases | Intraoperative Bleeding | Hemorrhage, Surgical

United States, Netherlands, Germany
LiteVax BV
University Hospital, Ghent

Completed

Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin (TETRALITE-I)

Influenza

Belgium
Boston Scientific Corporation
Cardialysis BV

Unknown

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries (SYNTAX)

Coronary Artery Disease

United States, Italy, Latvia, Netherlands, United Kingdom, France, Spain, Sweden, Germany, Hungary, Poland, Portugal, Austria, Belgium, Norway, Czech Republic, Denmark, Finland
University Medical Center Groningen
University of Twente; Vivisol; Löwenstein BV; Sencure BV

Not yet recruiting

Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach (NOCTIVENT)

Chronic Respiratory Failure | Non-invasive Ventilation
Aplagon Oy
TRACER Europe BV

Recruiting

Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography) (CHASE)

Peripheral Arterial Occlusive Disease | Critical Limb Ischemia

Netherlands
Ziekenhuis Oost-Limburg
Synapse bv

Recruiting

COAgulation Disorders in Ischaemic and Haemorrhagic Stroke (COADIHS)

Ischemic Stroke | Aneurysmal Subarachnoid Hemorrhage | Haemorrhagic Stroke

Belgium
Hy2Care BV
UMC Utrecht; Avania

Recruiting

Advanced Cartilage Treatment With Injectable-hydrogel Validation of the Effect (ACTIVE)

Cartilage Damage

Netherlands
University Hospital, Bordeaux
Synapse bv

Not yet recruiting

Drug Interactions in Hospital Information System. The PRoSIT System.. (PROSIT)

Drug Interaction

France
ECRI bv
Boston Scientific Corporation

Active, not recruiting

Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures (IVUS-CHIP)

Complex Coronary Lesions

Spain, United Kingdom, Netherlands, France, Belgium, Germany, Italy
ECRI bv
Micell Technologies; Stentys

Completed

Study Comparing the MiStent SES Versus the XIENCE EES Stent (DESSOLVE III)

Coronary Stenosis

France, Germany, Netherlands, Poland
Amarna Stem Cells BV
Neuroplast

Unknown

Bone Marrow Collection in Healthy Volunteers (iCell) (iCell)

Spinal Cord Injury

Netherlands
Columbia University
Delphi Devices BV

Completed

Feasibility of Delphi Screener for Cervical Cytology

Cervical Neoplasia

United States
Skyline Diagnostics BV
Illumina, Inc.

Terminated

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

Acute Myeloid Leukemia (AML) | Acute Promyelocytic Leukemia (APL) | Refractory Anemia With Excess of Blasts (RAEB)

United States, Germany, Netherlands, United Kingdom
CoreAalst BV
Abbott Medical Devices

Recruiting

FAME II-10-year Follow-Up (FAME2-10yFU)

Coronary Artery Disease

United States, Netherlands, Denmark, United Kingdom, Sweden, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Serbia
Orexa BV
QPS Holdings LLC

Recruiting

Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy. (ORE001PIIPOI)

Ileus Postoperative

Germany
CoreAalst BV
Abbott Medical Devices

Recruiting

Exercise and Coronary Microvascular Disease (ExerciseCMD)

Coronary Microvascular Disease

Belgium
Nucletron Operations BV
Factory CRO

Completed

Post Market Clinical Follow-up Study Venezia

Cervical Cancer

Austria, Netherlands, Germany

Clinical Trials Sponsored by LanthioPep BV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations